NTRK1 and cancer: Finding BRAF mutations or PPARG, NTRK1, NTRK3 and ALK fusions were strong predictors of a higher risk of cancer (approaching 100%) while other mutations like RAS, PTEN and EIF1AX or THADA fusions were associated with a significant but lower risk of cancer [25].